Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Krueger, J. G. TI - The immunologic basis for the treatment of psoriasis with new biologic agents JA - J. Am. Acad. Dermatol. PY - 2002/// VL - 46 SP - 1 EP - 23 M3 - 10.1067/mjd.2002.120568 N1 - 10.1067/mjd.2002.120568 UR - http://dx.doi.org/10.1067/mjd.2002.120568 ER - TY - JOUR AU - Lebwohl, M. TI - Psoriasis JA - Lancet PY - 2003/// VL - 361 SP - 1197 EP - 1204 M3 - 10.1016/S0140-6736(03)12954-6 N1 - 10.1016/S0140-6736(03)12954-6 UR - http://dx.doi.org/10.1016/S0140-6736(03)12954-6 ER - TY - JOUR AU - Nickoloff, B. J. AU - Nestle, F. O. TI - Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities JA - J. Clin. Invest. PY - 2004/// VL - 113 SP - 1664 EP - 1675 M3 - 10.1172/JCI200422147 N1 - 10.1172/JCI200422147 UR - http://dx.doi.org/10.1172/JCI200422147 ER - TY - JOUR AU - Bowcock, A. M. AU - Krueger, J. G. TI - Getting under the skin: the immunogenetics of psoriasis JA - Nature Rev. Immunol. PY - 2005/// VL - 5 SP - 699 EP - 711 M3 - 10.1038/nri1689 N1 - 10.1038/nri1689 UR - http://dx.doi.org/10.1038/nri1689 ER - TY - JOUR AU - Schon, M. P. AU - Boehncke, W. H. TI - Psoriasis JA - N. Engl. J. Med. PY - 2005/// VL - 352 SP - 1899 EP - 1912 M3 - 10.1056/NEJMra041320 N1 - 10.1056/NEJMra041320 UR - http://dx.doi.org/10.1056/NEJMra041320 ER - TY - JOUR AU - Gaspari, A. A. TI - Innate and adaptive immunity and the pathophysiology of psoriasis JA - J. Am. Acad. Dermatol. PY - 2006/// VL - 54 SP - S67 EP - S80 M3 - 10.1016/j.jaad.2005.10.057 N1 - 10.1016/j.jaad.2005.10.057 UR - http://dx.doi.org/10.1016/j.jaad.2005.10.057 ER - TY - JOUR AU - Davidson, A. AU - Diamond, B. TI - Autoimmune diseases JA - N. Engl. J. Med. PY - 2001/// VL - 345 SP - 340 EP - 350 M3 - 10.1056/NEJM200108023450506 N1 - 10.1056/NEJM200108023450506 UR - http://dx.doi.org/10.1056/NEJM200108023450506 ER - TY - JOUR AU - Liu, Y. AU - Krueger, J. G. AU - Bowcock, A. M. TI - Psoriasis: genetic associations and immune system changes JA - Genes Immunity PY - 2006/11/09/ ER - TY - JOUR AU - Christensen, T. E. TI - Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes JA - J. Invest. Dermatol. PY - 2006/// VL - 126 SP - 2397 EP - 2403 M3 - 10.1038/sj.jid.5700489 N1 - 10.1038/sj.jid.5700489 UR - http://dx.doi.org/10.1038/sj.jid.5700489 ER - TY - JOUR AU - Lew, W. AU - Lee, E. AU - Krueger, J. G. TI - Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris JA - Br. J. Dermatol. PY - 2004/// VL - 150 SP - 668 EP - 676 M3 - 10.1111/j.0007-0963.2004.05891.x N1 - 10.1111/j.0007-0963.2004.05891.x UR - http://dx.doi.org/10.1111/j.0007-0963.2004.05891.x ER - TY - JOUR AU - Clark, R. A. TI - The vast majority of CLA+ T cells are resident in normal skin JA - J. Immunol. PY - 2006/// VL - 176 SP - 4431 EP - 4439 ER - TY - JOUR AU - Boyman, O. TI - Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis JA - Br. J. Dermatol. PY - 2005/// VL - 152 SP - 1211 EP - 1218 M3 - 10.1111/j.1365-2133.2005.06701.x N1 - 10.1111/j.1365-2133.2005.06701.x UR - http://dx.doi.org/10.1111/j.1365-2133.2005.06701.x ER - TY - JOUR AU - Boyman, O. TI - Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-[alpha] JA - J. Exp. Med. PY - 2004/// VL - 199 SP - 731 EP - 736 M3 - 10.1084/jem.20031482 N1 - 10.1084/jem.20031482 UR - http://dx.doi.org/10.1084/jem.20031482 ER - TY - JOUR AU - Lew, W. AU - Bowcock, A. M. AU - Krueger, J. G. TI - Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and 'Type 1' inflammatory gene expression JA - Trends Immunol. PY - 2004/// VL - 25 SP - 295 EP - 305 M3 - 10.1016/j.it.2004.03.006 N1 - 10.1016/j.it.2004.03.006 UR - http://dx.doi.org/10.1016/j.it.2004.03.006 ER - TY - JOUR AU - Nestle, F. O. TI - Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production JA - J. Exp. Med. PY - 2005/// VL - 202 SP - 135 EP - 143 M3 - 10.1084/jem.20050500 N1 - 10.1084/jem.20050500 UR - http://dx.doi.org/10.1084/jem.20050500 ER - TY - JOUR AU - Lowes, M. A. TI - Increase in TNF-[alpha] and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a) JA - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 19057 EP - 19062 M3 - 10.1073/pnas.0509736102 N1 - 10.1073/pnas.0509736102 UR - http://dx.doi.org/10.1073/pnas.0509736102 ER - TY - JOUR AU - Larrengina, A. T. AU - Falo, L. D. TI - Changing paradigms in cutaneous immunology: adapting with dendritic cells JA - J. Invest. Dermatol. PY - 2005/// VL - 124 SP - 1 EP - 12 ER - TY - JOUR AU - Serbina, N. V. AU - Salazar-Mather, T. P. AU - Biron, C. A. AU - Kuziel, W. A. AU - Pamer, E. G. TI - TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection JA - Immunity PY - 2003/// VL - 19 SP - 59 EP - 70 M3 - 10.1016/S1074-7613(03)00171-7 N1 - 10.1016/S1074-7613(03)00171-7 UR - http://dx.doi.org/10.1016/S1074-7613(03)00171-7 ER - TY - JOUR AU - Lee, E. TI - Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris JA - J. Exp. Med. PY - 2004/// VL - 199 SP - 125 EP - 130 M3 - 10.1084/jem.20030451 N1 - 10.1084/jem.20030451 UR - http://dx.doi.org/10.1084/jem.20030451 ER - TY - JOUR AU - Wang, F. TI - Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects JA - J. Invest. Dermatol. PY - 2006/// VL - 126 SP - 1590 EP - 1599 M3 - 10.1038/sj.jid.5700310 N1 - 10.1038/sj.jid.5700310 UR - http://dx.doi.org/10.1038/sj.jid.5700310 ER - TY - JOUR AU - Zhou, X. TI - Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array JA - Physiol. Genomics PY - 2003/// VL - 13 SP - 69 EP - 78 ER - TY - JOUR AU - Weninger, W. TI - Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis JA - J. Immunol. PY - 2003/// VL - 170 SP - 4638 EP - 4648 ER - TY - JOUR AU - Weninger, W. AU - von Andrian, U. H. TI - Chemokine regulation of naive T cell traffic in health and disease JA - Semin. Immunol. PY - 2003/// VL - 15 SP - 257 EP - 270 M3 - 10.1016/j.smim.2003.08.007 N1 - 10.1016/j.smim.2003.08.007 UR - http://dx.doi.org/10.1016/j.smim.2003.08.007 ER - TY - JOUR AU - McKenzie, B. S. AU - Kastelein, R. A. AU - Cua, D. J. TI - Understanding the IL-23-IL-17 immune pathway JA - Trends Immunol. PY - 2006/// VL - 27 SP - 17 EP - 23 M3 - 10.1016/j.it.2005.10.003 N1 - 10.1016/j.it.2005.10.003 UR - http://dx.doi.org/10.1016/j.it.2005.10.003 ER - TY - JOUR AU - Nickoloff, B. J. AU - Bonish, B. AU - Huang, B. B. AU - Porcelli, S. A. TI - Characterization of a T cell line bearing natural killer receptors and capable of creating psoriasis in a SCID mouse model system JA - J. Dermatol. Sci. PY - 2000/// VL - 24 SP - 212 EP - 225 M3 - 10.1016/S0923-1811(00)00120-1 N1 - 10.1016/S0923-1811(00)00120-1 UR - http://dx.doi.org/10.1016/S0923-1811(00)00120-1 ER - TY - JOUR AU - Prinz, J. C. TI - T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products JA - Eur. J. Immunol. PY - 1994/// VL - 24 SP - 593 EP - 598 ER - TY - JOUR AU - Sugiyama, H. TI - Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation JA - J. Immunol. PY - 2005/// VL - 174 SP - 164 EP - 173 ER - TY - JOUR AU - Gottlieb, S. L. TI - Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis JA - Nature Med. PY - 1995/// VL - 1 SP - 442 EP - 447 M3 - 10.1038/nm0595-442 N1 - 10.1038/nm0595-442 UR - http://dx.doi.org/10.1038/nm0595-442 ER - TY - JOUR AU - Abrams, J. R. TI - CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris JA - J. Clin. Invest. PY - 1999/// VL - 103 SP - 1243 EP - 1252 ER - TY - JOUR AU - Abrams, J. R. TI - Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells JA - J. Exp. Med. PY - 2000/// VL - 192 SP - 681 EP - 694 M3 - 10.1084/jem.192.5.681 N1 - 10.1084/jem.192.5.681 UR - http://dx.doi.org/10.1084/jem.192.5.681 ER - TY - JOUR AU - Wolk, K. TI - IL-22 increases the innate immunity of tissues JA - Immunity PY - 2004/// VL - 21 SP - 241 EP - 254 M3 - 10.1016/j.immuni.2004.07.007 N1 - 10.1016/j.immuni.2004.07.007 UR - http://dx.doi.org/10.1016/j.immuni.2004.07.007 ER - TY - JOUR AU - Finch, P. W. AU - Murphy, F. AU - Cardinale, I. AU - Krueger, J. G. TI - Altered expression of keratinocyte growth factor and its receptor in psoriasis JA - Am. J. Pathol. PY - 1997/// VL - 151 SP - 1619 EP - 1628 ER - TY - JOUR AU - Bowcock, A. M. TI - The genetics of psoriasis and autoimmunity JA - Annu. Rev. Genomics Hum. Genet. PY - 2005/// VL - 6 SP - 93 EP - 122 M3 - 10.1146/annurev.genom.6.080604.162324 N1 - 10.1146/annurev.genom.6.080604.162324 UR - http://dx.doi.org/10.1146/annurev.genom.6.080604.162324 ER - TY - JOUR AU - Elder, J. T. TI - The genetics of psoriasis JA - Arch. Dermatol. PY - 1994/// VL - 130 SP - 216 EP - 224 M3 - 10.1001/archderm.130.2.216 N1 - 10.1001/archderm.130.2.216 UR - http://dx.doi.org/10.1001/archderm.130.2.216 ER - TY - JOUR AU - Tiilikainen, A. AU - Lassus, A. AU - Karvonen, J. AU - Vartiainen, P. AU - Julin, M. TI - Psoriasis and HLA-Cw6 JA - Br. J. Dermatol. PY - 1980/// VL - 102 SP - 179 EP - 184 M3 - 10.1111/j.1365-2133.1980.tb05690.x N1 - 10.1111/j.1365-2133.1980.tb05690.x UR - http://dx.doi.org/10.1111/j.1365-2133.1980.tb05690.x ER - TY - JOUR AU - Veal, C. D. TI - Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus JA - Am. J. Hum. Genet. PY - 2002/// VL - 71 SP - 554 EP - 564 M3 - 10.1086/342289 N1 - 10.1086/342289 UR - http://dx.doi.org/10.1086/342289 ER - TY - JOUR AU - Nair, R. P. TI - Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene JA - Am. J. Hum. Genet. PY - 2006/// VL - 78 SP - 827 EP - 851 M3 - 10.1086/503821 N1 - 10.1086/503821 UR - http://dx.doi.org/10.1086/503821 ER - TY - JOUR AU - Helms, C. TI - Localization of PSORS1 to a haplotype block harboring HLA-C and distinct from corneodesmosin and HCR JA - Hum. Genet. PY - 2005/// VL - 118 SP - 466 EP - 476 M3 - 10.1007/s00439-005-0048-2 N1 - 10.1007/s00439-005-0048-2 UR - http://dx.doi.org/10.1007/s00439-005-0048-2 ER - TY - JOUR AU - Helms, C. TI - A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis JA - Nature Genet. PY - 2003/// VL - 35 SP - 349 EP - 356 M3 - 10.1038/ng1268 N1 - 10.1038/ng1268 UR - http://dx.doi.org/10.1038/ng1268 ER - TY - JOUR AU - Huffmeier, U. TI - Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients JA - J. Med. Genet. PY - 2006/// VL - 43 SP - 517 EP - 522 M3 - 10.1136/jmg.2005.037515 N1 - 10.1136/jmg.2005.037515 UR - http://dx.doi.org/10.1136/jmg.2005.037515 ER - TY - JOUR AU - Tsunemi, Y. TI - Interleukin-12 p40 gene (IL12B) 3[prime]-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris JA - J. Dermatol. Sci. PY - 2002/// VL - 30 SP - 161 EP - 166 M3 - 10.1016/S0923-1811(02)00072-5 N1 - 10.1016/S0923-1811(02)00072-5 UR - http://dx.doi.org/10.1016/S0923-1811(02)00072-5 ER - TY - JOUR AU - Koks, S. TI - Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis JA - Genes Immun. PY - 2004/// VL - 5 SP - 662 EP - 667 M3 - 10.1038/sj.gene.6364141 N1 - 10.1038/sj.gene.6364141 UR - http://dx.doi.org/10.1038/sj.gene.6364141 ER - TY - JOUR AU - Foerster, J. TI - Evaluation of the IRF-2 gene as a candidate for PSORS3 JA - J. Invest. Dermatol. PY - 2004/// VL - 122 SP - 61 EP - 64 M3 - 10.1046/j.0022-202X.2003.22104.x N1 - 10.1046/j.0022-202X.2003.22104.x UR - http://dx.doi.org/10.1046/j.0022-202X.2003.22104.x ER - TY - JOUR AU - Tomfohrde, J. TI - Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q JA - Science PY - 1994/// VL - 264 SP - 1141 EP - 1145 M3 - 10.1126/science.8178173 N1 - 10.1126/science.8178173 UR - http://dx.doi.org/10.1126/science.8178173 ER - TY - JOUR AU - Hwu, W. L. TI - Mapping of psoriasis to 17q terminus JA - J. Med. Genet. PY - 2005/// VL - 42 SP - 152 EP - 158 M3 - 10.1136/jmg.2004.018564 N1 - 10.1136/jmg.2004.018564 UR - http://dx.doi.org/10.1136/jmg.2004.018564 ER - TY - JOUR AU - Birnbaum, R. Y. TI - Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein JA - Nature Genet. PY - 2006/// VL - 38 SP - 749 EP - 751 M3 - 10.1038/ng1813 N1 - 10.1038/ng1813 UR - http://dx.doi.org/10.1038/ng1813 ER - TY - JOUR AU - Nestle, F. O. AU - Nickoloff, B. J. TI - From classical mouse models of psoriasis to a spontaneous xenograft model featuring use of AGR mice JA - Ernst Schering Res. Found. Workshop PY - 2005/// SP - 203 EP - 212 ER - TY - JOUR AU - Villadsen, L. S. TI - Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model JA - J. Clin. Invest. PY - 2003/// VL - 112 SP - 1571 EP - 1580 M3 - 10.1172/JCI200318986 N1 - 10.1172/JCI200318986 UR - http://dx.doi.org/10.1172/JCI200318986 ER - TY - JOUR AU - Weinberg, J. M. AU - Bottino, C. J. AU - Lindholm, J. AU - Buchholz, R. TI - Biologic therapy for psoriasis: an update on the tumor necrosis factor inhibitors infliximab, etanercept, and adalimumab, and the T-cell-targeted therapies efalizumab and alefacept JA - J. Drugs Dermatol. PY - 2005/// VL - 4 SP - 544 EP - 555 ER - TY - JOUR AU - Gottlieb, A. B. TI - Psoriasis: emerging therapeutic strategies JA - Nature Rev. Drug Discov. PY - 2005/// VL - 4 SP - 19 EP - 34 M3 - 10.1038/nrd1607 N1 - 10.1038/nrd1607 UR - http://dx.doi.org/10.1038/nrd1607 ER - TY - JOUR AU - Papp, K. A. TI - The long-term efficacy and safety of new biological therapies for psoriasis JA - Arch. Dermatol. Res. PY - 2006/// VL - 298 SP - 7 EP - 15 M3 - 10.1007/s00403-006-0660-6 N1 - 10.1007/s00403-006-0660-6 UR - http://dx.doi.org/10.1007/s00403-006-0660-6 ER - TY - JOUR AU - Ellis, C. N. AU - Krueger, G. G. TI - Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes JA - N. Engl. J. Med. PY - 2001/// VL - 345 SP - 248 EP - 255 M3 - 10.1056/NEJM200107263450403 N1 - 10.1056/NEJM200107263450403 UR - http://dx.doi.org/10.1056/NEJM200107263450403 ER - TY - JOUR AU - Chamian, F. TI - Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris JA - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 2075 EP - 2080 M3 - 10.1073/pnas.0409569102 N1 - 10.1073/pnas.0409569102 UR - http://dx.doi.org/10.1073/pnas.0409569102 ER - TY - JOUR AU - Vugmeyster, Y. TI - Efalizumab (anti-CD11a)-induced increase in leukocyte numbers in psoriasis patients is preferentially mediated by blocked entry of memory CD8+ T cells into the skin JA - Clin. Immunol. PY - 2004/// VL - 113 SP - 38 EP - 46 M3 - 10.1016/j.clim.2004.06.001 N1 - 10.1016/j.clim.2004.06.001 UR - http://dx.doi.org/10.1016/j.clim.2004.06.001 ER - TY - JOUR AU - Gottlieb, A. B. TI - TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques JA - J. Immunol. PY - 2005/// VL - 175 SP - 2721 EP - 2729 ER - TY - JOUR AU - Kruger-Krasagakis, S. AU - Galanopoulos, V. K. AU - Giannikaki, L. AU - Stefanidou, M. AU - Tosca, A. D. TI - Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis JA - Br. J. Dermatol. PY - 2006/// VL - 154 SP - 460 EP - 466 M3 - 10.1111/j.1365-2133.2005.07078.x N1 - 10.1111/j.1365-2133.2005.07078.x UR - http://dx.doi.org/10.1111/j.1365-2133.2005.07078.x ER - TY - JOUR AU - Boruchov, A. M. TI - Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions JA - J. Clin. Invest. PY - 2005/// VL - 115 SP - 2914 EP - 2923 M3 - 10.1172/JCI24772 N1 - 10.1172/JCI24772 UR - http://dx.doi.org/10.1172/JCI24772 ER - TY - JOUR AU - Dupasquier, M. AU - Stoitzner, P. AU - van Oudenaren, A. AU - Romani, N. AU - Leenen, P. J. TI - Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis JA - J. Invest. Dermatol. PY - 2004/// VL - 123 SP - 876 EP - 879 M3 - 10.1111/j.0022-202X.2004.23427.x N1 - 10.1111/j.0022-202X.2004.23427.x UR - http://dx.doi.org/10.1111/j.0022-202X.2004.23427.x ER - TY - JOUR AU - Chen, D. M. AU - Gordon, K. AU - Leonardi, C. AU - Menter, M. A. TI - Adalimumab efficacy and safety in patients with moderate to severe chronic plaque psoriasis: preliminary findings from a 12-week dose-ranging trial JA - J. Am. Acad. Dermatol. PY - 2004/// VL - 50 SP - 1 M3 - 10.1016/j.jaad.2003.10.008 N1 - 10.1016/j.jaad.2003.10.008 UR - http://dx.doi.org/10.1016/j.jaad.2003.10.008 ER - TY - JOUR AU - Gottlieb, A. B. TI - Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial JA - Br. J. Dermatol. PY - 2005/// VL - 152 SP - 1219 EP - 1227 M3 - 10.1111/j.1365-2133.2005.06661.x N1 - 10.1111/j.1365-2133.2005.06661.x UR - http://dx.doi.org/10.1111/j.1365-2133.2005.06661.x ER - TY - JOUR AU - Toichi, E. TI - An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis JA - J. Immunol. PY - 2006/// VL - 177 SP - 4917 EP - 4926 ER - TY - JOUR AU - Xia, Y. P. TI - Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis JA - Blood PY - 2003/// VL - 102 SP - 161 EP - 168 M3 - 10.1182/blood-2002-12-3793 N1 - 10.1182/blood-2002-12-3793 UR - http://dx.doi.org/10.1182/blood-2002-12-3793 ER - TY - JOUR AU - Blumberg, H. TI - Interleukin 20: discovery, receptor identification, and role in epidermal function JA - Cell PY - 2001/// VL - 104 SP - 9 EP - 19 M3 - 10.1016/S0092-8674(01)00187-8 N1 - 10.1016/S0092-8674(01)00187-8 UR - http://dx.doi.org/10.1016/S0092-8674(01)00187-8 ER - TY - JOUR AU - Zenz, R. TI - Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins JA - Nature PY - 2005/// VL - 437 SP - 369 EP - 375 M3 - 10.1038/nature03963 N1 - 10.1038/nature03963 UR - http://dx.doi.org/10.1038/nature03963 ER - TY - JOUR AU - Haider, A. S. AU - Duculan, J. AU - Whynot, J. A. AU - Krueger, J. G. TI - Increased JunB mRNA and protein expression in psoriasis vulgaris lesions JA - J. Invest. Dermatol. PY - 2006/// VL - 126 SP - 912 EP - 914 M3 - 10.1038/sj.jid.5700183 N1 - 10.1038/sj.jid.5700183 UR - http://dx.doi.org/10.1038/sj.jid.5700183 ER - TY - JOUR AU - Zheng, Y. TI - Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis JA - Nature PY - 2006/12/24/ ER -